RG

Ranno Gupta

Active Director Director DIN 09393147
DIN 09393147 First appointment Nov 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Ranno Gupta

Data last updated:

Ranno Gupta is a Director at Winmed Health Care Private Limited (since 2021). The company operates in Trading. Winmed Health Care Private Limited reported revenue of ₹48.8 Lakh (FY 2025).

DIN 09393147
Primary Designation Director
Industry Trading
First Appointment 10 Nov 2021
Oldest Company Age 4 yrs
Largest company Winmed Health Care Private Limited · ₹48.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Winmed Health Care Private Limited U51909MP2021PTC058327
Director10 Nov 20212021₹48.8 Lakh (FY 2025)Active

Board colleagues of Ranno Gupta

Directorship timeline

Open interactive timeline →
Winmed Health Care Private Limited
Premium access

Shareholding and investment profile for Ranno Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranno Gupta

Ranno Gupta currently holds 1 directorship: Winmed Health Care Private Limited (Director, since 10 Nov 2021, revenue ₹48.8 Lakh (FY 2025)).

Ranno Gupta was first appointed on 10 Nov 2021 as Director at Winmed Health Care Private Limited.

The current boards of Ranno Gupta's companies include Priyanka Kumari (Winmed Health Care Private Limited), Santosh (Winmed Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available